OOIR: Observatory of International Research

Papers

(The TQCC of Blood Coagulation & Fibrinolysis is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
The role of thrombin in haemostasis	47
Comparing the efficacy and safety of direct oral anticoagulants versus Vitamin K antagonists in patients with antiphospholipid syndrome: a systematic review and meta-analysis	17
Coronavirus disease 2019 and coagulopathy: other prothrombotic coagulation factors	16
Marked von Willebrand factor and factor VIII elevations in severe acute respiratory syndrome coronavirus-2-positive, but not severe acute respiratory syndrome coronavirus-2-negative, pneumonia: a case	16
Outcomes of patients with thromboembolic events following coronavirus disease 2019 AstraZeneca vaccination: a systematic review and meta-analysis	16
Blood biocompatibility enhancement of biomaterials by heparin immobilization: a review	15
Reduced cleavage of von willebrand factor by ADAMTS13 is associated with microangiopathic acute kidney injury following trauma	13
The incidence of venous thromboembolic events in trauma patients after tranexamic acid administration: an EAST multicenter study	13
Thrombogenicity markers for early diagnosis and prognosis in COVID-19: a change from the current paradigm?	13
The physiology of hemostasis	13
Evaluating the potential benefits of the extravascular pool of factor IX	11
Vascular activation is a strong predictor of mortality in coronavirus disease 2019 patients on the ICU	11
Antiphospholipid antibodies in patients with coronavirus disease 2019 infection hospitalized in conventional unit	11
A mild deficiency of ADAMTS13 is associated with severity in COVID-19: comparison of the coagulation profile in critically and noncritically ill patients	10
Coronavirus disease 2019 in patients with chronic immune thrombocytopenia on thrombopoietin receptor agonists: new perspectives and old challenges	10
ChAdOx1 nCoV-19 vaccine-associated thrombocytopenia: three cases of immune thrombocytopenia after 107 720 doses of ChAdOx1 vaccination in Thailand	9
First report of COVID-19 vaccine induced flare of compensated congenital thrombotic thrombocytopenic purpura	9
Relationship between serum soluble endothelial protein C receptor level and COVID-19 findings	9
Thromboprophylaxis with argatroban in critically ill patients with sepsis: a review	9
Clinical safety and efficacy of thrombolytic therapy with low-dose prolonged infusion of tissue type plasminogen activator in patients with intermediate-high risk pulmonary embolism	9
Risk of venous thromboembolism and endocrine therapy in older women with breast cancer in the United States	9
How to use low-molecular-weight heparin to treat neonatal thrombosis in clinical practice	8
Comparison of different activators of coagulation by turbidity analysis of hereditary dysfibrinogenemia and controls	8
Human coagulation factor IX: a systematic review of its characteristics	7
Immune thrombocytopenia: options and new perspectives	7

Platelet hyperaggregability and venous thrombosis risk: results from the RETROVE project	7
Thrombin generation assay: the present and the future	7
Direct oral anticoagulant neutralization by activated charcoal DOAC-Remove for thrombophilia screening	7
Reversal of factor Xa inhibitors associated intracranial haemorrhage at a tertiary medical centre	7
Application of microfluidic chip technology to study the inhibitory effect of tetramethylpyrazine on platelet aggregation, activation, and phosphatidylserine exposure mediated by pathological high she	7
Viscoelastic hemostasis assays in septic, critically ill coronavirus disease 2019 patients: a practical guide for clinicians	7
Acquired factor V inhibitor in the setting of coronavirus disease 2019 infection	7
Derangement of the coagulation process using subclinical markers and viscoelastic measurements in critically ill patients with coronavirus disease 2019 pneumonia and non-coronavirus disease 2019 pneum	7
Tranexamic acid versus aminocapróic acid in multiple doses via the oral route for the reduction of postoperative bleeding in total primary hip arthroplasty: a prospective, randomized, double-blind, co	6
Use of thrombolytic agents to treat neonatal thrombosis in clinical practice	6
Increased resistance to fibrinolysis activation in patients with coronavirus disease 2019: a case series	6
Management of surgery, menorrhagia and child-birth for patients with unclassified bleeding disorders: a systematic review of cohort studies	6
Screening hemostatic defects in Saudi University students with unexplained menorrhagia: a diagnosis, which could be missed	6
HbA1c/C-peptide ratio is associated with angiographic thrombus burden and short-term mortality in patients presenting with ST-elevation myocardial infarction	6
Tranexamic acid rapidly inhibits fibrinolysis, yet transiently enhances plasmin generation in vivo	6
Subcutaneous injection of mRNA vaccines against severe acute respiratory syndrome coronavirus 2: an option for severe bleeding disorders or anticoagulated patients?	6
A prospective cohort study of catheter-related thrombosis in cancer patients treated with 1 month of anticoagulation after catheter removal	6
Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator-induced hyperfibrinolysis in full-term pregnant women: a prospective interventional study	6
Factors associated with deep venous thrombosis in patients infected with coronavirus disease 2019: a meta-analysis	6
Risk factors for antibody formation in children with hemophilia: methodological aspects and clinical characteristics of the HEMFIL cohort study	5
Age, sex and racial differences in fibrin formation and fibrinolysis within the healthy population	5
Harmonizing factor assay-related testing performed in a large laboratory network	5
In-vitro thromboelastographic characterization of reconstituted whole blood utilizing cryopreserved platelets	5
Assessment of endothelial progenitor cells, VEGF-A and SDF-1α in Hodgkin's lymphoma	5
Psychological complications among patients with congenital bleeding disorders	5
Interleukin-10 levels and the risk of thromboembolism according to COMPASS-Cancer associated thrombosis score in breast cancer patients prior to undergoing doxorubicin-based chemotherapy	5
A pilot randomized trial of atorvastatin as adjunct therapy in patients with acute venous thromboembolism	5
Global sources of cryoprecipitate demonstrate variability in coagulant factor levels and functional hemostasis	5
Clinical characteristics and outcomes of patients with isolated pulmonary embolism	5
A challenging case of heparin-induced skin necrosis without thrombocytopenia	4
Epidemiological study about the mental state of patients after a pulmonary embolism or deep venous thrombosis event	4
Mannose-binding lectin-associated serine protease-1 cleaves plasminogen and plasma fibronectin: prefers plasminogen over known fibrinogen substrate	4
Interference of icterus on plasma D-dimer levels measured using immunoturbidimetric assays	4
Significant difference between coagulation parameters and clinicopathological characteristics in breast cancer	4
Evaluation of 4Ts score inter-rater agreement in patients undergoing evaluation for heparin-induced thrombocytopenia	4
General concepts on hemophilia A and on women carrying the disease	4
Hemophilia carriers: quality of life and management at different life stages	4
Homozygous methylentetrahydrofolate reductase C667T genotype anticipates age at venous thromboembolism by one decade	4
Type II antithrombin deficiency caused by a novel missense mutation (p.Leu417Gln) in a Chinese family	4
Weekly low-dose recombinant factor VIIa prophylaxis in Glanzmann thrombasthenia	4
Venous thromboembolism and acute myeloid leukemia: risk factors and mortality in elderly white, black and Asian patients	4
Microparticles: a link to increased thrombin generation	4
Direct oral anticoagulant adsorption and laboratory detection of lupus anticoagulant	4
Direct oral anticoagulants in patients with antiphospholipid syndrome: a retrospective study in a real-life patient cohort	4
Lupus anticoagulant activity and thrombosis post COVID-19 vaccination	4
Apoptosis in platelets from adult patients with chronic idiopathic thrombocytopenic purpura	4
The evaluation of reactive oxygen species generation and free mitochondrial DNA in platelet concentrates during 5 days of storage	3
Challenges and concerns of patients with congenital bleeding disorders affected by coronavirus disease 2019	3
Effect of remote ischemic preconditioning on fibrin formation and metabolism in patients undergoing hip fracture surgery: a randomized clinical trial	3
Foundations of hemophilia and epidemiology	3

New under the sun: ClotPro's ECA-test detects hyperfibrinolysis in a higher number of patients, more frequently and 9 min earlier	3
A study of fibrinolytic system components in donor groups depending on various titers of circulating anti-SARS-CoV-2 IgG in the bloodstream	3
A founder effect in hemophilia A patients from Russian Ural region with a new p.(His634Arg) variant in F8 gene	3
Very low-dose recombinant Factor VIIa administration for cardiac surgical bleeding reduces red blood cell transfusions and renal risk: a matched cohort study	3
Microkinetic coagulation assays for human and zebrafish plasma	3
Cost-effectiveness of thrombotic thrombocytopenic purpura diagnosis: a retrospective analysis in the University Hospital Center of Lyon (France)	3
Difficulty in controlling heavy menstrual bleeding at menarche in a patient with Glanzmann's thrombasthenia	3
Ruthenium-based antivenom attenuates Crotalus atrox venom mediated coagulopathy in rabbits	3
Soluble thrombomodulin and cardiovascular disease risk factors in Japanese children	3
Pulmonary vein stump thrombosis after lung resection for lung cancer: clinical features and outcome	3
New developments in the diagnosis of primary immune thrombocytopenia	3
Anticoagulation management post-transjugular intrahepatic portosystemic shunt in portal hypertension associated with myeloproliferative neoplasms	3
Fibrinogen reflects severity and predicts outcomes in patients with sepsis and septic shock	3
Spinal epidural hematoma in a child with hemophilia A with high titer inhibitors and follow-up with prophylactic emicizumab: case report and literature review	3
Primary immune thrombocytopenia: a ‘diagnosis of exclusion’?	3
Cangrelor for cardiopulmonary bypass in patients with heparin-induced thrombocytopenia: it is not so easy	3
Effects of Momordica charantia exosomes on platelet activation, adhesion, and aggregation	3
The effect of tranexamic acid on myocardial injury in cardiac surgical patients: a systematic review and meta-analysis	3
The impact of atorvastatin on dabigatran plasma levels in patients with atrial fibrillation	3
Eltrombopag treatment for severe immune thrombocytopenia during pregnancy: a case report	3